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RESEARCH ARTICLE
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Abstract Mitochondrial transport in axons is critical for neural circuit health and function. While
several proteins have been found that modulate bidirectional mitochondrial motility, factors that
regulate unidirectional mitochondrial transport have been harder to identify. In a genetic screen,
we found a zebrafish strain in which mitochondria fail to attach to the dynein retrograde motor.
This strain carries a loss-of-function mutation in actr10, a member of the dynein-associated complex
dynactin. The abnormal axon morphology and mitochondrial retrograde transport defects
observed in actr10 mutants are distinct from dynein and dynactin mutant axonal phenotypes. In
addition, Actr10 lacking the dynactin binding domain maintains its ability to bind mitochondria,
arguing for a role for Actr10 in dynactin-mitochondria interaction. Finally, genetic interaction
studies implicated Drp1 as a partner in Actr10-dependent mitochondrial retrograde transport.
Together, this work identifies Actr10 as a factor necessary for dynactin-mitochondria interaction,
enhancing our understanding of how mitochondria properly localize in axons.
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Mitochondrial transport in axons is critical for the formation and function of the nervous system. This
organelle generates the ATP necessary for energy demanding functions in all cells, but neurons are
especially reliant on mitochondria to maintain their electrically polarized state. After depolarization,
ATP-dependent ion pumps are employed to repolarize the cell and prepare it for another action
potential. It is estimated that at rest alone, neurons use 4.7 billion molecules of ATP per second
(Zhu et al., 2012). Because of this large ATP requirement, mitochondria need to be properly localized to regions of high ion influx, such as at synapses (reviewed in Schwarz, 2013). In addition to
their critical role in cellular metabolism, mitochondria also regulate local calcium ion levels
(Werth and Thayer, 1994). Calcium efflux from intracellular stores mediates synaptic activity. During
inactivity, this ion needs to be contained in intracellular compartments as high cytoplasmic calcium
levels correlate with axonal degeneration (Avery et al., 2012; Vargas et al., 2015; Yang et al.,
2013). The proper localization of mitochondria to sites of high ATP consumption and calcium ion
flux requires active transport.
In addition to maintaining axon health, mitochondrial motility is also necessary to maintain mitochondrial health and function. Mitochondria undergo fission-fusion dynamics that facilitate both the
replenishment of proteins in this organelle and the maintenance of mitochondrial DNA quantity and
integrity (reviewed in Scheibye-Knudsen et al., 2015). Interrupted mitochondrial fission or fusion
has been linked to loss of mitochondrial DNA, loss of oxidative potential, and mitophagy. Axonal
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transport of mitochondria is tightly linked to mitochondrial dynamics as mitochondrial fusion requires
the coalescence of mitochondria and fission requires the active separation of dividing organelles.
The relationship between mitochondrial dynamics and transport is also apparent at the molecular
level: Mitofusin, an essential protein for mitochondrial fusion, participates in the anterograde transport of this organelle as well (Misko et al., 2010). Furthermore, manipulation of the dynamin-like
protein Drp1, necessary for mitochondrial fission, impacts the localization of mitochondria
(Smirnova et al., 2001; Varadi et al., 2004). The mechanistic bases for these relationships are still
largely unclear.
Elegant work in Drosophila, C. elegans, and cultured neurons has begun to elucidate the mechanisms of mitochondrial axonal transport. The primary anterograde mitochondrial motor, Kinesin-1,
attaches to mitochondria via the proteins Miro (RhoT1/2; Guo et al., 2005) and Milton (TRAK1/2;
Glater et al., 2006; Stowers et al., 2002). Miro contains calcium sensitive EF hands that, when
exposed to high levels of this ion, change their confirmation, resulting in the uncoupling of the Kinesin-1 motor from microtubules (Saotome et al., 2008; Wang and Schwarz, 2009). This mechanism,
in conjunction with mitochondrial tethering factors (Kang et al., 2008), allows mitochondrial congregation at sites of high synaptic activity. The Miro/Milton transport machinery is not specific for anterograde transport, however, as loss of either protein impacts anterograde and retrograde
mitochondrial movement (Guo et al., 2005; Saotome et al., 2008). Therefore, how mitochondria
are specifically moved in a unidirectional manner by either the Kinesin or Dynein motor protein complex is not well understood.
Retrograde mitochondrial transport is known to depend on the cytoplasmic dynein complex
(Pilling et al., 2006; Schnapp and Reese, 1989). The core dynein motor (reviewed in Holzbaur and
Vallee, 1994) is oftentimes associated with dynactin, itself a multi-protein complex, during retrograde axonal transport. Dynactin, specifically its p150 subunit, has been shown to facilitate dynein
processivity and also serves as an anchor for dynein at microtubule plus ends, facilitating cargo loading (Lloyd et al., 2012; Moughamian and Holzbaur, 2012; Schroer, 2004). The dynactin accessory
complex is attached to dynein through interaction of p150 with the tails of the dynein intermediate
chains (Vaughan and Vallee, 1995). In addition to p150, dynactin contains two actin-related proteins, Arp1 and Actr10 (also known as Arp11; Eckley et al., 1999; Eckley and Schroer, 2003).
Together with p25, p62 and p27, Actr10 is a part of the dynactin pointed end complex which is predicted to be in an ideal location for cargo binding (Yeh et al., 2012). Structural work suggests that
one key function for Actr10 is capping the actin-like Arp1 filament, to regulate filament length and
facilitate attachment of other pointed end proteins (Urnavicius et al., 2015); however, this does not
preclude an additional role for Actr10 in cargo attachment to the dynein complex, a function which
has not been explored.
In a forward genetic screen for mediators of retrograde axonal transport, we identified a strain
with a loss-of-function mutation in Actr10. actr10nl15 mutants (hereafter referred to as actr10) display
axon terminal swellings in the central and peripheral nervous systems indicative of retrograde transport abnormalities. Analysis of cargo localization and movement in the actr10 mutant revealed clustering of mitochondria, but not other cargos analyzed, at microtubule plus ends due to failed
retrograde mitochondrial movement. This phenotype was vastly different from loss of either Dynein
heavy chain or p150, potentially indicating a unique function for Actr10 in mitochondrial retrograde
movement. Furthermore, we demonstrated that abnormal mitochondrial movement in actr10
mutants is due to failed attachment of mitochondria to the dynein-dynactin complex in the absence
of Actr10. Importantly, Actr10 engineered to lack the dynactin binding domain maintains mitochondrial interaction, hinting at a specific role for Actr10 in mediating dynactin-mitochondria interaction.
Finally, we provide biochemical and genetic evidence that Drp1, a Dynamin-related protein previously implicated in microtubule minus end-directed mitochondrial movement (Smirnova et al.,
1998), partners with Actr10 in mitochondrial retrograde transport. Together our data support a
model in which Actr10 functions to scaffold mitochondria to the dynein-dynactin complex for retrograde transport in axons.
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Results
Mitochondria accumulate in actr10 mutant axon terminals due to failed
retrograde transport
We used the zebrafish posterior lateral line (pLL) system to identify novel mediators of retrograde
cargo transport in axons (Drerup and Nechiporuk, 2013). pLL axons develop early (axon extension
is complete by 2 days post-fertilization (dpf) and synapse formation occurs by 4 dpf), are superficially
localized and are largely planar, making them an ideal system for in vivo observations and manipulations (Figure 1A; Ghysen and Dambly-Chaudière, 2004; Metcalfe, 1985; Metcalfe et al., 1985).
Using an ENU-based forward genetic screen, we isolated a larval-lethal, recessive mutant strain with
large swellings in pLL axon terminals (Figure 1B). RNAmapper analysis (Miller et al., 2013) identified the causal mutation as a single nucleotide change (T to G) in the start codon of actr10. We confirmed actr10 as the affected gene using RNA-mediated rescue of axon terminal swellings and by
performing TALEN- (Transcription Activator Like Effector Nuclease) mediated disruption of the first
exon of actr10, which phenocopied the mutant axon terminal swellings (Figure 1C–F).
Axonal swellings, like those observed in actr10 mutants, can arise due to a number of intracellular
abnormalities, including disruptions in retrograde cargo transport (Drerup and Nechiporuk, 2013;
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Figure 1. actr10 mutants have swollen axon terminals. (A) Wild-type larva (pigment free) at 4 dpf carrying the neurod:egfp BAC transgene. By 4 dpf,
pLL axons are fully extended and functional synapses have formed with hair cells of primary neuromasts. (B) actr10 mutant axons fully extend but
terminals display large swellings. Posterior lateral line ganglion (pLLg) and innervation of the third neuromast (NM3) are indicated. Insets in (A) and (B)
show magnified NM3 axon terminals. Arrows in inset point to swellings. Asterisks label areas of the pLL nerve obscured by pigment in the mutant. (C)
The mutant axon terminal swelling phenotype can be suppressed by exogenous expression of mRFP-Actr10 in a dose-dependent manner. Proportion
of mutants with axon terminal swellings is depicted. (D–F) Injection of TALENS targeting exon 1 of the actr10 genomic locus phenocopies the actr10
mutant axon terminal swelling phenotype in F0 injected larvae (arrows). Axons are labeled by the neurod:egfp BAC transgene (white). Scale bars in A,
B = 100 mm.
DOI: 10.7554/eLife.22234.002
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Martin et al., 1999). To determine if a particular cargo was accumulating in actr10 mutant axon terminals, indicative of impaired retrograde movement, we performed immunolabeling on mutants and
wildtype siblings at 4 dpf with antibodies against various axonal cargos. This revealed an accumulation of Cytochrome c, a mitochondrial protein, in actr10 axon terminals (Figure 2A,B,E). To confirm
mitochondrial accumulation in mutant axon terminals, mitochondria were labeled in neurons with
TagRFP by zygotic injection of a plasmid containing a mitochondrial targeting sequence tagged with
this fluorescent protein (5kbneurod:mito-TagRFP). actr10 mutants displayed mitochondrial accumulation in pLL axon terminals (Figure 2C,D). Other known pLL axon retrograde cargos, including
those labeled by Lamp1 (Lysosome associated membrane protein-1; late endosome/lysosome
marker) and phosphorylated c-Jun N-Terminal Kinase (pJNK) did not accumulate (Figure 2F–K;
Drerup and Nechiporuk, 2013). Expression of wildtype Actr10 using zygotic injection of in vitro
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Figure 2. Loss of Actr10 causes mitochondrial accumulation in swollen axon terminals. (A,B) At 4 dpf, swollen axon terminals in actr10 mutants (B) have
high levels of Cytochrome c immunolabeling (arrow; NM3 shown) relative to a wildtype sibling (A). (C,D) TagRFP-labeled mitochondria accumulate in
actr10 mutant (arrow), but not wildtype, axon terminals at 4 dpf. (E) Mean fluorescence intensity (background subtracted) of Cytochrome C in axon
terminals of A and B. (F,G) Mean fluorescence intensity (background subtracted) in axon terminals of H-K show comparable levels of Lamp1 and pJNK
fluorescence intensity between wildtype and actr10 mutant terminals (ANOVA; mean ± SEM shown). (H–K) Lamp1 and pJNK immunolabeling in NM3
axon terminals (arrows). Lamp1 and pJNK are in red in (H–K) and white in H‘-K‘. (L–O) Mitochondrial accumulation in mutant axon terminals, assayed
using Cytochrome c immunolabeling (white), can be suppressed by mRNA-mediated expression of mRFP-Actr10. Arrows point to axon terminal regions
for comparison. Scale bars = 10 mm.
DOI: 10.7554/eLife.22234.003
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synthesized mRNA rescued mitochondrial accumulation in actr10 mutants (Figure 2L–O), confirming
that Actr10 is necessary for proper mitochondrial positioning.
As our immunolabeling experiments were not exhaustive for every possible cargo in axons, we
undertook transmission electron microscopy (TEM) analyses of pLL axon terminals to determine if
mitochondria are the predominant cargo mislocalized in actr10 mutants. This experiment demonstrated mitochondria are highly enriched in the axon terminal swellings of actr10 mutants compared
to other intracellular structures (Figure 3A,B; n = 3 wildtypes, n = 4 mutants). Together, our immunolabeling and TEM analyses showing mitochondrial accumulation in axon terminals could indicate
interrupted retrograde mitochondrial transport in actr10 mutants.
To determine if mitochondrial retrograde transport was disrupted in actr10 mutants, mitochondria in single pLL axons were tagged with TagRFP using 5kbneurod:mito-TagRFP plasmid injection
and organelle movement was visualized by confocal microscopy (Figure 4A,B; Videos 1 and
2). Kymograph analysis demonstrated a 37% and 39% reduction in the distance moved by mitochondria in the anterograde and retrograde directions respectively in actr10 mutants but no change in
mitochondrial transport velocity (Figure 4C–F). Despite the decrease in anterograde transport distance, the frequency of anterograde mitochondrial transport was unchanged in actr10 mutants. We
also analyzed reversal frequency to determine if there was a defect in directional persistence of mitochondrial transport in actr10 mutants but found no difference in the proportion of mitochondria that
reversed direction during our imaging sessions (wildtype: 0.011 ± 0.008; actr10 mutants:
0.000 ± 0.009; ANOVA; p=0.4003). In contrast, both the frequency of retrograde mitochondrial
transport and the proportion of mitochondria moving in the retrograde direction were dramatically
decreased in actr10 mutants (Figure 4G,H). As velocity of movement was largely normal, these data
suggest a role for Actr10 in the attachment of mitochondria to the retrograde motor for transport.
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Figure 3. TEM analysis of axon terminal swellings reveal mitochondrial accumulation. (A) Wild-type axon terminals
innervating lateral line neuromasts showed no swellings (N = 3). (B) All neuromasts assayed in actr10 mutants had
mitochondrial laden axon terminal swellings (N = 4). A‘ and B‘ are higher magnification views of the areas outlined
in A and B. Arrowheads in B‘ point to mitochondria.
DOI: 10.7554/eLife.22234.004

Drerup et al. eLife 2017;6:e22234. DOI: 10.7554/eLife.22234

5 of 25

Research article

Developmental Biology and Stem Cells Neuroscience

A

WT

40.48 sec

Time (sec)

47.52 sec

57.76

B

D 0
Time (sec)

C 0

actr10

00.00 sec
18.59 sec

actr10
69 µm

67

WT
52 µm

93

34.43 sec

0.6
0.4
0.2
12

9

0

0.0

0

tr1

10 10

0.8

ac

0.0

10 10

2

Still

p<0.01

W
T

0.5

4

Ant

Ret

1.0
Mito Ratio

1.0

H

p=0.898 p<0.0001

W
T
tr1
0

1.5

Ret

ac

10 10

6

p=0.420 p=0.060

Ant

W
T
tr1
0

0

10 10

W
ac T
tr1
0

2

G

ac

4

Ret

Mitochondria
100µm*min

6

2.0

Ant

W
ac T
tr1
0

p<0.05

F

W
ac T
tr1
0

p<0.05

W
ac T
tr1
0

Distance (µm)

Ret

{

8

Ant

Velocity (µm/sec)

E
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DOI: 10.7554/eLife.22234.005

Actr10 functions autonomously in neurons to regulate axon
morphology and mitochondrial localization
actr10 is ubiquitously expressed, albeit enriched in the nervous system during larval stages
(Figure 5A–C). As neuronal activity and the presence of growth factors can modulate mitochondrial
transport (Chada and Hollenbeck, 2004; Chen and Sheng, 2013), it was possible that changes in
the axonal environment in actr10 mutants could alter mitochondrial movement. This led us to ask if
Actr10 functions autonomously in axons to regulate mitochondrial transport. To test for a neuronspecific function for Actr10 in mitochondrial localization, we expressed monomeric red fluorescent
protein (mRFP) tagged Actr10 in individual pLL
neurons using zygotic injection of a 5kbneurod:
mRFP-actr10 DNA plasmid and assessed axon
terminals. While mRFP-Actr10 expression in wildtype axons had no apparent effects (Figure 5D;
n = 6 in 3 biological replicates), it rescued axon
Video 1. Mitochondrial transport in a 4 dpf wildtype
terminal morphology and mitochondrial localizalarva, related to Figure 4. Yellow arrowheads indicate
tion in all mutants analyzed (Figure 5E–G; n = 5
mitochondria moving in the anterograde direction. Red
mutants in 3 biological replicates). These experi- arrowhead marks retrograde mitochondrial movement.
ments confirmed a neuron-specific function for Scale bar = 10 mm
Actr10 in mitochondrial localization in axons.
DOI: 10.7554/eLife.22234.006
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Dynein localization and motility
does not rely on Actr10
Previous work on Actr10 function assayed
mitotic spindle positioning during cell division in
cultured fibroblasts and nuclear positioning in
fungi to show that Actr10 depletion phenocopied dynein loss of function (Lee et al., 2001;
Yeh et al., 2012; Zhang et al., 2008). In association with structural work implicating Actr10 in
Arp1 filament capping (Urnavicius et al., 2015), these data could imply that loss of Actr10 impacts
dynactin integrity and, subsequently, all dynein function. However, the aforementioned work could
also be interpreted to mean that appropriate dynactin-nuclear membrane interaction requires
Actr10 function. Supporting this possibility, Actr10 has been shown to regulate dynactin-membrane
association (Clark and Rose, 2006). With this data in mind, we next wanted to determine if loss of
Actr10 phenocopied dynein or dynactin loss of function in mature neurons, the cell type that
Video 2. Mitochondrial transport in a 4 dpf actr10
mutant larva, related to Figure 4. Yellow arrowheads
indicate mitochondria moving in the anterograde
direction. Scale bar = 10 mm
DOI: 10.7554/eLife.22234.007
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displayed specific defects in mitochondrial retrograde transport in our studies. First, we analyzed the
localization of dynein and dynactin in actr10 mutant axons at 4 dpf. Neither Dynein heavy chain
(DHC) nor p150 were significantly mislocalized in actr10 mutants, though we did observe a trend of
increased DHC in actr10 mutant axon terminals (Figure 6A–F). Next, to determine if dynein was
able to move in the retrograde direction, we assayed dynein motility by tagging the core motor
complex using expression of an mRFP tagged variant of dynein light intermediate chain (5kbneurod:
dync1li1V2-mRFP; Figure 6G,H; Videos 3 and 4). Kymograph analysis revealed no change in the
parameters of retrograde dynein movement, though we did note a 42% reduction in the distance
and a 26% reduction in the velocity of anterograde dynein transport. Despite these defects in anterograde dynein transport, there was no change in the proportion of dynein-positive puncta moving in
the anterograde or retrograde direction in actr10 mutants at 4 dpf (Figure 6I–M). Additionally, we
analyzed reversal frequency to determine if there was a defect in persistence of dynein movement in
actr10 mutants but found no difference in the average number of puncta that reversed direction during our imaging sessions (wildtype: 1.62/100 mm*min ±0.37; actr10 mutants: 1.74/100 mm*min ±0.44;
ANOVA; p=0.844). These experiments demonstrated that loss of Actr10 does not impede dyneindynactin complex localization or dynein retrograde movement in axons.
We then analyzed the stability of dynein-dynactin interaction using co-immunoprecipitation from
whole larval extracts. Immunoprecipitation of endogenous proteins was not possible due to lack of
zebrafish-specific antibodies, so we turned to overexpression of tagged dynein components using
zygotic injection of in vitro synthesized mRNA. First, we confirmed that a GFP tagged version of
dynein intermediate chain 2b (i2b), a core dynein protein, could integrate into the motor complex.
mRNA encoding i2b-GFP was injected into zygotes and anti-GFP antibodies were used to immunoprecipitate the complex. Extracts were subjected to western blot analysis and probed with antiDHC antibodies. i2b-GFP can integrate into the core dynein complex (Figure 6N). We then used
this approach to determine if loss of Actr10 impacts dynein-dynactin interaction. i2b-GFP was
expressed in actr10 mutants and wild-type siblings and larval extracts were subjected to GFP-based
immunoprecipitation at 4 dpf. Western blot of larval extracts revealed no change in p150 interaction
with the core dynein motor (Figure 6O). Together, these experiments confirmed that loss of Actr10
does not impact dynein-dynactin interaction.
To further explore the effect of loss of Actr10 on retrograde cargo transport, we analyzed the
movement of additional dynein cargos in axons. First, we visualized peroxisome transport in lateral
line axons (Videos 5 and 6). Kymograph analysis of peroxisome transport at 4 dpf demonstrated
small changes in anterograde transport velocity and distance of retrograde transport bouts
(Figure 7A–G). A slight, but not significant decrease in the proportion of peroxisomes moving in the
retrograde was apparent as well (Figure 7G; ANOVA; p=0.07). Upon further investigation, we found
that previous studies revealed a surprising relationship between mitochondria and peroxisomes,
including a large number of shared membrane proteins, such as Drp1 (reviewed in Schrader, 2006).
Our work implicates Drp1 in Actr10-dependent mitochondrial localization (see Figure 12), making
the impact of Actr10 loss of function on peroxisome transport complex. Therefore, we analyzed the
transport of a third cargo, Lamp1-labeled vesicles, which are composed of late endosomes and lysosomes. Analysis of Lamp1-positive vesicle movement at 4 dpf demonstrated that this cargo is transported normally in actr10 mutant axons (Figure 7H–L). These live imaging experiments, in
conjunction with the immunolabeling of known retrograde cargos (Figure 2) and our TEM studies
(Figure 3), argue that loss of Actr10 does not hinder the transport of all dynein-dependent, retrograde cargos in axons.
Since we observed small changes in retrograde peroxisome transport, we wanted to further investigate the relationship between loss of Actr10 and loss of dynein/dynactin. To do this, we analyzed
the ability of DHC and p150 null mutants to phenocopy actr10 mutants. First, we compared actr10
mutants to a previously isolated zebrafish DHC mutant, dync1h1mw20 (hereafter referred to as
dync1h1; Insinna et al., 2010). Unlike actr10 mutants (see Figure 1), dync1h1 mutants displayed
rapid degeneration of pLL axons by 4 dpf, with pLL nerves extending less than half-way to the tail at
this time-point (Figure 8A,B). Mitochondria do accumulate in distal axons of dync1h1 mutants, as
expected with global disruption of retrograde transport (Figure 8F,G). The disparity between actr10
and dync1h1 mutant axonal phenotypes argues that loss of Actr10 does not impact all dynein function in axons.
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Figure 6. Dynein-dynactin localization and retrograde movement are intact in actr10 mutants. (A,B) Dynein heavy chain (DHC) immunolabeling
demonstrates normal DHC localization in NM3 axon terminals of actr10 mutants at 4 dpf. (C,D) p150 is normally localized in NM3 axon terminals of
actr10 mutants at 4 dpf. (E,F) Analyses of mean fluorescence intensity in axon terminals (background subtracted) showed comparable fluorescence
intensity between mutant and wildtype siblings (ANOVA; mean ± SEM shown). (G,H) Stills from dynein time-lapse imaging sessions (Videos 3 and 4) in
wildtype and actr10 mutant pLL axons at 4 dpf. Arrowheads indicate retrograde dynein movement. (I,J) Kymograph analyses of dynein transport in
wildtype (I) and actr10 mutants (J). (K–M) Retrograde dynein transport parameters, including the proportion of dynein-labeled vesicles (K), distance
moved by vesicles (L) and velocity of movement (M) are unaffected in actr10 mutants (ANOVA; mean ± SEM shown). A reduction of anterograde
dynein-positive puncta distance and velocity was noted (ANOVA; mean ± SEM shown). (N) Dynein intermediated chain 2b fused to GFP (i2b-GFP)
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The core dynein complex labeled by i2b-GFP can immunoprecipitate p150 from whole larval lysates derived from wildtype and actr10 mutant larvae at
4 dpf (top). Whole larval lysate control for i2b-GFP (middle) and p150 (bottom). Bead only (no 1˚) and un-injected wildtype immunoprecipitation
controls shown. Scale bars = 10 mm. Number of larvae assayed is indicated on graphs.
DOI: 10.7554/eLife.22234.009
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Video 3. Dynein motility in a 4 dpf wildtype larvae,
related to Figure 6. Red arrowheads indicate dynein
positive cargo moving in the retrograde direction.
Scale bar = 10 mm
DOI: 10.7554/eLife.22234.010

Video 4. Dynein motility in a 4 dpf actr10 mutant larva,
related to Figure 6. Yellow arrowhead indicates dynein
positive puncta being passively carried in the
anterograde direction. Red arrowheads mark dynein
positive cargo moving in the retrograde direction.
Scale bar = 10 mm
DOI: 10.7554/eLife.22234.011

We then compared the actr10 mutant phenotype to loss of dynein-dynactin interaction using
zebrafish p150 mutants. There are two orthologs of p150 in zebrafish, p150a and p150b. These
paralogues are highly similar at the amino acid level but have slightly different expression patterns:
while both are ubiquitously expressed, p150b is enriched in developing (1 and 2 dpf) and mature (4
dpf) neurons while p150a is enriched only in mature neurons 4 dpf (Figure 9A–F). To determine
whether loss of p150 phenocopies the actr10 mutant, we assayed single and double p150 mutants
using a p150a mutant described previously (Del Bene et al., 2008; Wehman et al., 2005) and a
novel p150b mutant we engineered (p150bnl16). Loss of p150a alone has no discernable effect on
axons or mitochondrial localization (Figure 8C,H). We used CRISPR-Cas9 technology (Hwang et al.,
2013) to create a deletion in exon 3 of p150b, which resulted in a frame-shift and premature stop
site. p150b single mutants are indistinguishable from wild-type siblings at 4 dpf, with normal axon
terminals and no abnormalities in mitochondrial localization (Figure 8D,I). This strain does not have
the small eye phenotype observed in dync1h1 and p150a mutants (Figure 8A–D; Del Bene et al.,
2008; Insinna et al., 2010; Wehman et al., 2005). Unlike single p150 mutants, p150a/b mutants are
phenotypically similar to dync1h1 mutants, with truncated pLL axons and mitochondrial accumulation
at axon ends (Figure 8E,J). This confirms the reliance of mitochondria on the dynein-dynactin complex for retrograde movement and demonstrates that actr10 mutants do not phenocopy the axon
truncation phenotype of dynein or dynactin loss of function mutants.
We then analyzed the effect of p150 loss of function on mitochondrial transport in pLL axons.
Mitochondria were tagged with TagRFP using zygotic injection of the 5kbneurod:mito-TagRFP plasmid and kymograph analysis was performed on videos acquired through live imaging (Figure 8K–
N). Unlike loss of Actr10, p150a/b double mutants had an almost complete cessation of mitochondrial movement in the anterograde and retrograde directions (Figure 8N,O). In addition, we noted a
dramatic loss of mitochondria from the central portion of axons in p150a/b double mutants, likely
because of the strong defect in anterograde mitochondrial transport (Figure 8P). Analyses of transport parameters revealed no change in the distance or velocity of the residual mitochondrial movement in either direction (Figure 8Q,R). The dramatic loss of all mitochondrial movement in p150a/b
mutants, specifically reductions in both the anterograde and retrograde pools, is not observed in
actr10 mutants, which have only a reduction in the retrograde mitochondrial pool (see Figure 4).
Furthermore, two cargos known to localize normally in actr10 mutants, pJNK and Lamp1 (see Figure 2), accumulate in in p150a/b mutant axon terminals (Figure 10A–D), indicating that the retrograde transport of these cargos is perturbed by loss of dynein-dynactin interaction. Therefore, our

Video 5. Peroxisome motility in a 4 dpf wildtype larvae,
related to Figure 7. Yellow arrowhead points to a
peroxisome moving in the anterograde direction. Red
arrowhead indicates a peroxisome moving in the
retrograde direction. Scale bar = 10 mm
DOI: 10.7554/eLife.22234.013

Drerup et al. eLife 2017;6:e22234. DOI: 10.7554/eLife.22234

Video 6. Peroxisome motility in a 4 dpf actr10 mutant
larva, related to Figure 7. Yellow arrowheads indicate
peroxisomes moving in the anterograde direction. Red
arrowhead marks peroxisome moving in the retrograde
direction. Scale bar = 10 mm
DOI: 10.7554/eLife.22234.014
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Figure 7. Peroxisome and Lamp1 vesicle transport in actr10 mutants at 4 dpf. (A,B) Stills from peroxisome imaging sessions at 4 dpf from Videos 5 and
6. Yellow and red arrowheads point to anterograde and retrograde peroxisome movement respectively. (C,D) Kymographs analyses of peroxisome
transport in wildtype (C) and actr10 mutants (D). (E–G) Peroxisome transport parameters were similar between actr10 mutants and wildtype siblings,
though a slight reduction in retrograde distance and anterograde velocity were noted (ANOVA; mean ± SEM shown). The proportion of peroxisomes
moving in the retrograde direction was reduced as well, though not significantly (ANOVA; mean ± SEM shown; p=0.07). (H,I) Kymographs of Lamp1labeled vesicle movement at 4dpf. (J–L) Lamp1 vesicles were transported similarly between wildtype and actr10 mutants. An increase in the proportion
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DOI: 10.7554/eLife.22234.012

phenotypic, in vivo transport, immunolabeling and biochemical data fail to support the argument
that loss of Actr10 impacts all dynein-dynactin function in axons and, instead, supports a specific
requirement for Actr10 in mitochondrial retrograde transport in this neuronal compartment.

Mitochondria fail to attach to the dynein-dynactin complex in actr10
mutants
The specific effect of Actr10 depletion on retrograde mitochondrial transport frequency led us to
ask if Actr10 is necessary to attach this organelle to the dynein motor complex. We addressed this
question using mitochondrial fractionation from whole larvae (Figure 11A; Prudent et al., 2013).
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Figure 8. dync1h1 and p150a/b mutants fail to phenocopy actr10 mutants. (A) Wildtype larva at 4 dpf with full pLL axon extension into the tail. End of
pLL nerve indicated by arrowhead. (B) Loss of DHC in dync1h1 mutants results in pLL axon degeneration, leading to a truncated pLL nerve at 4 dpf.
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Figure 8 continued on next page
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Figure 8 continued
truncated, thin pLL nerves with swellings along the length of axons and in terminals and are indistinguishable from dync1h1 mutants. p150a/b mutants
also show small eyes similar to dync1h1 and p150a mutants. (F,G) dync1h1 mutants display axon terminal swellings and mitochondrial accumulation
compared to wildtype controls at 4 dpf. Arrows point to mitochondria rich, axonal swellings. Mitochondria are labeled by expression of mito-TagRFP
(red on top F-J, white below F‘-J‘). (H,I) p150a and p150b single mutants have axon terminal morphology and mitochondrial localization in axon
terminals similar to wildtype siblings. (J) Loss of both p150 paralogues (p150a/b; J) results in swollen axon terminals with increased mitochondrial
density similar to dync1h1 mutants (G). (K–N) Kymograph analyses of mitochondrial transport in p150 mutants. (O) The proportion of mitochondria
moving in both the anterograde and retrograde direction in pLL axons is significantly decreased in p150a/b double mutants (ANOVA with Tukey HSD
post-hoc contrasts). (P) The number of mitochondria in pLL axons is decreased in p150a mutants compared to wildtype siblings (ANOVA with Tukey
HSD post-hoc contrasts; *p<0.05). The number of mitochondria in pLL axons of p150a/b double mutants is dramatically reduced compared to wildtype
siblings (ANOVA with Tukey HSD post-hoc contrasts; mean±SEM shown). (Q,R) Distance and velocity of limited residual mitochondrial movement is not
significantly altered in p150a/b mutants compared to wildtype siblings (ANOVA with Tukey HSD post-hoc contrasts; mean ± SEM shown). Scale bars in
A-E = 100 mm. Scale bars in F-J = 10 mm. Number of larvae assayed is indicated on graphs.
DOI: 10.7554/eLife.22234.015

Analysis of fractions revealed equal levels of p150 in the input and heavy fractions between wildtype
and actr10 mutants. Strikingly, in actr10 mutants, p150 was largely lost from the mitochondrial fraction with a concomitant increase of p150 to the light fraction, which contains all cellular components
not pelleted under low centrifugation speeds (Figure 11B,C). This result demonstrates the necessity
of Actr10 for mitochondrial attachment to dynactin.
To better define the mechanism of dynactin-Actr10-mitochondrial interaction, we identified the
domain in Actr10 necessary for association with the dynactin complex using immunoprecipitation of
deletion constructs (overlapping deletion of 40 amino acid regions) from HEK293T cells. Whereas
Actr1047–410 deletions showed reduced binding to dynactin, Actr1047 most consistently failed to
immunoprecipitate dynactin in all experiments (Figure 11E,F; n = 4). As this result was somewhat
variable in HEK cells, we confirmed the necessity of this domain for Actr10-dynactin interaction in
vivo using immunoprecipitation of Actr10 and Actr1047 from embryo lysates. This revealed a loss of
interaction between Actr1047 and dynactin, demonstrating the reliance of Actr10 on this region for
interaction with dynactin (Figure 11G; n = 3). Finally, if Actr10 is a part of the scaffold necessary for
mitochondria-dynactin interaction, a separate mitochondrial binding domain likely exists in Actr10. If
this is the case, Actr10 lacking the dynactin binding domain should maintain its interaction with mitochondria. To address this, we assayed the ability of Actr1047 to bind mitochondria using mitochondrial fractionation. mRFP-Actr10 and mRFP-Actr1047, expressed using zygotic microinjection of
respective mRNAs, were both present in the mitochondrial fractionation (Figure 11D,H; n = 2), arguing that separate protein domains exist in Actr10 which are necessary for interaction with dynactin
and mitochondria. This data supports a role for Actr10 in binding mitochondria to dynactin for retrograde mitochondrial transport.

Drp1 functions with Actr10 in mitochondrial retrograde transport
It is unlikely that Actr10 binds directly to mitochondria as it does not have predicted transmembrane
or other membrane-associated domains. Rather, similar to Kinesin-1-mitochondrial attachment, there
are likely partner proteins that facilitate this interaction (Glater et al., 2006; Guo et al., 2005). Literature searches revealed a particularly strong association between Drp1 (Dynamin related protein 1),
a GTPase associated with mitochondrial fission, and mitochondrial localization. Specifically, a lysine
to alanine mutation at amino acid 38 in Drp1 (mimicking a constitutively GDP-bound form) causes
clustering of mitochondria in the perinuclear region of fibroblasts in a microtubule-dependent manner (Smirnova et al., 2001; Varadi et al., 2004). Using immunoprecipitation, we demonstrated that
Drp1 interacts with Actr10, with strongly enhanced interaction between Actr10 and the Drp1K38A
variant (Figure 12A; n = 3 replicates in independent experiments; (Smirnova et al., 2001, 1998).
Next, we asked whether Drp1 works with Actr10 to regulate mitochondrial retrograde transport
in vivo. To address this, we examined the genetic interaction between Drp1 and Actr10 in mitochondrial localization in pLL neurons. We reasoned that if Drp1 and Actr10 function in the same pathway,
Drp1 manipulation would impact the location of mitochondria in wildtype but not actr10 mutant
axons. We expressed Drp1-mRFP, Drp1K38A-mRFP, and cytoplasmic mRFP (control) in pLL neurons
using injection of a plasmid encoding the respective open reading frame under an inducible
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Figure 9. p150a and p150b expression in zebrafish embryos and larvae. (A,C,E,E‘) p150a in situ hybridization shows ubiquitous expression at 1 and 2
dpf, with a slight enrichment in neurons of the pLL ganglion at 4 dpf. (B,D,F,F‘) p150b is enriched in developing neurons with low level expression
ubiquitously at all stages assayed. pLL and anterior lateral line ganglia are indicated by an arrowhead or arrow respectively in all. *=ear. Higher
magnification views of the ear, pLL ganglia, and anterior lateral line ganglia shown in insets in B‘, D‘, E‘, and F‘. Scale bars in A-F = 100 mm. Scale bars
in B‘ and D‘-F‘=20 mm.
DOI: 10.7554/eLife.22234.016

promotor. Mitochondria were labeled by 5kbneurod:mito-EGFP co-injection. In wild-type larvae,
expression of Drp1K38A-mRFP caused mitochondrial clustering in the perinuclear region, phenotypically similar to the results observed in cultured fibroblasts (Figure 12B,C; Smirnova et al., 2001;
Varadi et al., 2004). In contrast, Drp1K38A-mRFP expression did not alter mitochondrial localization
in actr10 mutant pLL neurons (Figure 12D,E). If Drp1K38A mediates retrograde mitochondrial movement, we predicted its expression would induce movement of mitochondria from the proximal axon
into the cell body, leading to loss of mitochondrial occupation of the axon. Indeed, expression of
Drp1K38A caused a substantial decrease in the number of mitochondria per micron in wildtype but
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Figure 10. pJNK and Lamp1 accumulate in p150a/b pLL axon terminals. (A,B) pJNK accumulates in axon terminals
at 4 dpf in p150a/b double mutants. NM3 shown. (C,D) Lamp1 accumulates in NM4 axon terminals at 5 dpf in
p150a/b double mutants. Arrows point to axon terminals in wildtype and p150a/b double mutants in all. Axons are
labeled by the neurod:egfp BAC transgene (green). Lamp1 and pJNK are show in red in A-D and white in A‘-D‘.
Scale bars = 10 mm.
DOI: 10.7554/eLife.22234.017

not actr10 mutant axons (Figure 12F–J). Notably, actr10 mutants already have reduced mitochondrial occupation of pLL axons which could impact the fraction of mitochondria capable of motility in
this assay. More definitive analyses of Drp1’s role in Actr10-dependent mitochondrial motility will be
the subject of continued investigation. Together, the biochemical and genetic interaction between
Actr10 and Drp1K38A support a model in which Drp1, in its GDP-bound state, modulates dyneinbased mitochondrial localization via an Actr10-dependent mechanism.

Discussion
Using genetics, immunolabeling, biochemistry, and in vivo imaging of cargo movement, we have
identified Actr10 as a mediator of retrograde mitochondrial transport. In the absence of this dynactin pointed end protein, mitochondrial retrograde transport frequency is selectively disrupted, leading to accumulation of this organelle in axon terminals. Importantly, the anterograde transport of
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Figure 11. Actr10 is essential for mitochondria-dynactin interaction. (A) Schematic of whole embryo mitochondrial fractionation. (B) While the level of
p150 in the input and heavy fractions are comparable between wildtype and actr10 mutants, p150 is shifted from the mitochondrial to light fraction in
actr10 mutants. ATPb western blot from the same extracts (bottom) serves as a mitochondrial loading control. (C) Quantification of p150 intensity
(normalized to mitochondrial loading) in actr10 mutants relative to wildtype. (D) Quantification of p150 intensity (normalized to mitochondrial loading) in
mRFP-Actr1047 expressing embryos relative to those expressing mRFP-Actr10. (E) Schematic and sequence of the 47 region in Actr10. (F)
Immunoprecipitation of EGFP-Actr10 deletion constructs from HEK293T cells identified the 47 region as critical for Actr10’s interaction with the
dynactin complex (n = 4 replicates). (G) In zebrafish embryos, mRFP-Actr1047, expressed by zygotic injection of in vitro synthesized mRNA, was unable
to interact with dynactin (top). mRFP-Actr10 and mRFP-Actr1047 (middle) and p150 (bottom) are all present at similar levels. Bead only (no 1˚)
immunoprecipitation controls shown. (H) Actr1047 is able to interact with mitochondria in zebrafish embryos as assayed by mitochondrial fractionation.
ATPb mitochondrial loading control (bottom).
DOI: 10.7554/eLife.22234.018

mitochondria, the localization and transport of other cargos assayed, the localization of dyneindynactin components as well as dynein retrograde movement are all largely intact in the absence of
Actr10, arguing for a role for Actr10 in mitochondrial retrograde transport in axons. Additionally,
Actr10 maintains its ability to interact with mitochondria without being incorporated into the dynactin complex, suggesting a specific role for this protein in linking this organelle to the retrograde
motor. Finally, we demonstrated that Actr10, perhaps through interaction with Drp1, links mitochondria to the dynactin complex. Our study brings us a step closer to understanding how unidirectional
mitochondrial transport is mediated in axons to maintain a functional neural circuit.
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mitochondrial targeting sequence tagged with EGFP (5kbneurod:mito-EGFP; green in B-I, white in B‘-I‘). (J) Quantification of mitochondrial number
normalized to mitochondrial size in the proximal axon (ANOVA with post-hoc contrasts; mean ± SEM shown). Scale bars = 10 mm. Number of larvae
assayed is indicated on graphs.
DOI: 10.7554/eLife.22234.019

Actr10s role in mitochondrial retrograde transport
We provide multiple pieces of evidence supporting a function for Actr10 in mitochondrial transport.
First, mitochondria are the only cargo analyzed whose localization or retrograde transport is significantly perturbed with loss of Actr10. If dynein-mediated cargo movement was generally disrupted,
other cargos, including lysosomes and dynein itself, would fail to move in the retrograde direction as
well. Second, the axonal phenotype of dynactin and dynein loss-of-function mutants is vastly different from actr10 mutants: dync1h1 and p150a/b mutants display pLL nerve degeneration at 4 dpf
while actr10 mutants do not. Third, loss of dynactin-dynein interaction in p150a/b mutants impedes
all mitochondrial transport, a phenotype that is not observed in actr10 mutants. Fourth, neither the
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localization of dynein and dynactin nor the retrograde movement of dynein are perturbed with loss
of Actr10. Lastly, we identified a domain in Actr10 (47) that is essential for interaction with the
dynactin complex but inconsequential for interaction with mitochondria. This piece of data is critical
as it demonstrates that Actr10 can interact with this organelle independently of dynactin, arguing for
a direct role for this protein in mitochondria-dynactin interaction. Together, our data argue that
Actr10 is necessary for dynactin-dependent, retrograde transport of mitochondria in axons.
Actr10 could directly link mitochondria to dynactin or potentially facilitate this interaction through
other dynactin pointed end proteins, such as p62. p62 is of particular interest in this regard as it is
predicted to rely on Actr10 for binding to the dynactin complex (Urnavicius et al., 2015). Based on
our current data, we cannot rule out a role for this protein in mitochondrial transport. Furthermore,
Actr10 interacting proteins, including p62, could have additional impacts on mitochondrial transport
parameters, including transport distance. As noted above, actr10 mutants have slight deficits in the
distance moved by mitochondria in both the anterograde and retrograde directions. While we cannot definitively ascertain the underlying mechanism of this disruption, at least three possibilities
exist. First, bidirectional transport distance could be affected by the abnormal localization of mitochondria. Mitochondrial localization directly affects local levels of ATP, which in turn could compromise the processive activity of ATP-dependent motors necessary for long distance transport.
Another possibility is local deficits in mitochondrial activity: if mitochondrial health is compromised,
this could account for the bidirectional transport deficits of mitochondria. Finally, it is possible that
Actr10 or its interacting proteins, such as p62, regulate motor engagement. It is largely thought that
cargos typically have anterograde and retrograde motors attached simultaneously and direction of
transport is attributed to regulation of motor engagement. More frequent oscillations in motor
engagement due to loss of Actr10 or Actr10 interactors could account for the shortened distances
moved by mitochondria in both directions. At this point, we do not have a full explanation for these
transport parameter alterations but they are a topic of continued interest.

Multiple roles for Actr10 in the cell
Our data does not preclude a function for Actr10 in the retrograde transport of additional cargos in
axons or other roles for Actr10, which could vary based on a number of factors including cell type
and developmental stage. Of particular interest is a potential role for Actr10 in peroxisome transport
through interaction with Drp1. While we did not find a statistically significant difference in the proportion of peroxisomes moving in the retrograde direction, there was a trend towards a decrease in
this population. As Drp1 is known to localize to peroxisome membranes as well (Schrader, 2006), it
will be interesting to further explore the interplay between these proteins and the transport of these
highly related organelles. In addition to cargo transport, one predicted function for Actr10, based
on structural and biochemical data, is in capping the Arp1 filament (Urnavicius et al., 2015). In support of this role, knockdown of Actr10 using siRNA in Cos7 cells resulted in dissociation of the
dynactin complex pointed end (Yeh et al., 2012). Additionally, studies in the fungi neurospora and
aspergillus demonstrated that loss of Actr10 phenocopies the abnormal nuclear positioning
observed with loss of dynein (Lee et al., 2001; Zhang et al., 2008). Similarly, zebrafish actr10
mutants display the small eye phenotype observed in dync1h1 and p150a mutants (see Figure 8 and
Del Bene et al., 2008; Insinna et al., 2010). Finally, similar to loss of p150, knockdown of Actr10
resulted in multipolar spindle formation in Cos7 cells (Yeh et al., 2012). Together, these data could
imply that Actr10 is in fact necessary for all dynein-dynactin activity through stabilizing the Arp1 filament; however, they could also be interpreted to mean that Actr10 is necessary for regulation of
Arp1-membrane interaction. Indeed, Actr10 has been shown to regulate Arp1-membrane interaction
(Clark and Rose, 2006) and the zebrafish eye phenotype in the p150a mutant is due to a defect in
interkinetic nuclear migration (Del Bene et al., 2008). This type of function for Actr10 could also
explain the nuclear positioning defect in the actr10 loss of function studies in fungi (Lee et al., 2001;
Zhang et al., 2008). Therefore, rather than purely serving a stabilizing role for the dynactin complex,
Actr10 may modulate both Arp1 interaction with the nuclear membrane and mitochondria-dynactin
binding in axons. How these functions are disparately regulated in different cell types, in different
cellular compartments and/or at varying developmental stages is still unclear.
Given the previous data implicating Actr10 in Arp1 capping and subsequent dynactin stability
and dynein function (Urnavicius et al., 2015; Yeh et al., 2012; Zhang et al., 2008), we were presented with the challenge of confirming that Actr10 has a specific function in mitochondrial
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retrograde transport and reconciling our work with these previous studies. As outlined above, our
evidence for a role for Actr10 in mitochondrial transport specifically includes: (1) actr10 mutant axons
are not phenotypically identical to dync1h1 or p150 mutants; (2) mitochondrial retrograde, but not
anterograde, transport is disrupted in actr10 mutants while all mitochondrial movement is inhibited
in p150a/b mutants; and (3) localization and transport of all other cargos are not disrupted in actr10
mutants. Together, these results argue that loss of Actr10 does not impact all dynein-dynactin function. In addition, a variant of Actr10 lacking the dynactin binding domain retains its ability to interact
with mitochondria, further substantiating a direct role for this protein in mitochondria-dynactin interaction. Together, our data argue that Actr10 participates in mitochondrial attachment to the retrograde motor protein complex in neurons in addition to potentially facilitating Arp1 capping and
nuclear positioning in other contexts.

Drp1 and Actr10 function together to regulate mitochondrial
retrograde transport
The interaction between Drp1 and Actr10 in mitochondrial retrograde transport may provide a link
between mitochondrial movement and mitochondrial fission. Originally, we investigated the role of
Drp1 in retrograde mitochondrial transport as previous studies revealed the unique ability of this
GTPase to elicit mitochondrial localization to microtubule minus ends (Smirnova et al., 2001,
1998). Upon further investigation, it became apparent that a select number of proteins implicated in
mitochondrial fission and fusion, including Drp1, have been shown to be essential for mitochondrial
transport. Specifically, the fusion-related protein Mitofusin binds to the Miro-Milton complex and is
necessary for mitochondrial movement (Misko et al., 2010). Similar to Miro and Milton, loss of Mitofusin results in decreased anterograde and retrograde mitochondrial transport in cultured neurons
(Misko et al., 2010). Interestingly, the inner mitochondrial membrane protein Opa1, also necessary
for mitochondrial fusion, does not participate in transport (Misko et al., 2010). Thus, eliminating
mitochondrial fusion itself does not impact mitochondrial movement; rather mitochondrial outer
membrane proteins may have dual roles in fusion-fission dynamics and transport.
Similarly, our work in conjunction with other studies supports the argument that Drp1 participates
in both mitochondrial fission and retrograde mitochondrial transport. Drp1 translocates to mitochondria where it can bind to receptors Fis1 and Mff (LosonLosón et al., 2013). In its GTP-bound form, it
then oligomerizes, forming a constrictable collar necessary for fission during which GTP is exchanged
for GDP (Ingerman et al., 2005). We found that a Drp1 variant incapable of binding GTP stimulates
mitochondrial accumulation at the nuclear periphery, linking fission with transport. Our genetic interaction data suggest that Actr10 functions with Drp1 in this process, though further experiments are
necessary to confirm this. Rather than Actr10 working with Drp1 to regulate mitochondrial localization, it is also possible that loss of Actr10 results a decrease in the motile pool of mitochondria in
axons upon which Drp1K38A could work. We cannot differentiate between these possibilities at this
point. Nevertheless, given the intriguing data generated here, it is tempting to speculate that, upon
the GTP-GDP transition, not only do mitochondria undergo fission but Drp1 also recruits the retrograde motor protein complex through interaction with Actr10 to facilitate separation of these
daughter mitochondria. The precise nature of Drp1-Actr10 interaction and the role of this interaction
in mitochondrial retrograde transport is a subject of current investigation.

Conclusions
The coordinated regulation of mitochondrial transport is necessary for the formation and maintenance of active neural circuits. Our work identifies Actr10 as a crucial protein for mitochondrial interaction with the dynein-dynactin complex, regulating retrograde transport. In addition, we argue that
the role of Actr10 is specific and not due to a general loss of dynactin stability or dynein function.
The strongest pieces of evidence supporting this assertion are the ability of Actr10 to bind mitochondria in the absence of dynactin and the disparate nature of the actr10-dync1h1 and actr10p150a/b mutant phenotypes in axons. In addition, we identified Drp1, a GTPase implicated in mitochondrial fission, as an Actr10 interactor with a potential role in mitochondrial retrograde transport.
Together with previous studies on mitochondrial motility, a complex picture is emerging in which
mitochondrial transport and fission/fusion are dependent on a core group of proteins, with an independent set of proteins regulating mitochondrial docking. In conclusion, further work is crucial to
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understanding how mitochondrial transport and dynamics are orchestrated in axons, which will ultimately allow us to better understand how this critical organelle is positioned and maintained. As
mitochondrial transport and dynamics have been implicated in neurological disorders, a more complete mechanistic understanding of their regulation will provide insight into disease pathology.

Materials and methods
Zebrafish husbandry and strains
Adult *AB and WIK strains were maintained at 28.5˚C and spawned according to standard protocols
(Westerfield, 2000). ENU mutagenesis and mutant screening were performed as described previously (Mullins et al., 1994). Additional strains used include: TgBAC(neurod:egfp)nl1
(Obholzer et al., 2008), actr10nl15, dync1h1mw20 (Insinna et al., 2010), p150a (also known as
moks309; (Del Bene et al., 2008; Wehman et al., 2005), and p150bnl16.

RNA-seq based identification of the actr10nl15 mutation and
genotyping
RNAseq-based mapping was performed according to established protocols (Miller et al., 2013).
actr10 heterozygotes (*AB background) were crossed to WIKs to generate a mapping strain. Heterozygous F1 hybrids were identified using pair wise crosses. Eighty wildtypes/heterozygotes and 80
actr10 mutants were obtained from a single mapping pair. These larvae were lysed at 4 dpf in Trizol
according to the manufacturer’s protocol. mRNA was extracted in phenol:chloroform:isoamyl alcohol
and twice in chloroform before the pellet was redissolved in 20 mL of RNase/DNase free water.
Sequencing was performed by the OHSU Massively parallel sequencing core on an Illumina
HiSeq2000, generating approximately 30 million reads per condition. From this RNAseq data, RNAmapper identified a single nucleotide change in the start codon of the actr10 gene in the actr10nl15
mutant pool. The mutation (validated by sequencing and restriction digest of individual samples)
completely segregated with the mutant phenotype. For experiments, actr10 mutants were identified
by genotyping according to the following protocol: PCR amplification of the region around exon 1
of the actr10 locus resulted in a 374 bp product (forward primer: 5’-CTGTTTTCGGATGAACTGCC
TG; reverse primer: 5’-AGATGCTCTTCGTCTTCTGGCTA. The actr10 mutation inserts a HaeIII cut
site. Digestion with HaeIII generates wildtype (209 bp) and actr10 mutant (195 bp) bands.

Cloning the zebrafish ortholog of actr10, plasmid production, TALEN
synthesis, and mRNA synthesis
The full-length open reading frame of actr10 was cloned from a 2 dpf zebrafish cDNA library and
ligated into the pSC-A-amp/kan vector (Agilent Technologies; forward primer: 5’-AAATGCCCTTG
TTTGAA; reverse primer: 5’-TTTCTCAGTGGAGAAGG). All expression and mRNA synthesis vectors
were constructed using Gateway compatible cloning as described (Kwan et al., 2007). For Actr10
expression, the Actr10 open reading frame was PCR amplified with BP arms and inserted into the
Gateway compatible 3’-entry vector pDONRP2R-P3 (forward primer: 5’-ggggacaagtttgtacaaaaaagcaggctAAATGCCCTTGTTTGAA; reverse primer: 5’-ggggaccactttgtacaagaaagctgggtaTTTCTCAG
TGGAGAAGG). Other constructs used included: 5kbneurod:mito-TagRFP (modified from
(Fang et al., 2012); 5kbneurod:mRFP-dync1li1V2 (Drerup and Nechiporuk, 2013); Hsp701:mRFPpolyA; Hsp701:Drp1-mRFP; Hsp701:Drp1K38A-mRFP; and CMV/SP6:EGFP-dync1i2b. They were constructed as described here. The zebrafish dync1i2b ortholog was cloned into the pDONRP2P3 3’
entry vector using BP-competent primers (forward primer: 5’-ggggacagctttcttgtacaaagtggAGA
TGGCTCCCGTTTTAGAGAAG; reverse primer: 5’-ggggacaactttgtataataaagttgtTCATGCCTCGTTC
TCTGTC) and a 2 dpf zebrafish cDNA library. The zebrafish Drp1 ortholog was cloned from 2 dpf
cDNA, sequence verified, and cloned into the pDONR221 middle entry vector using BP cloning (forward
primer:
5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCAACGCGATGGAGGCTCTTA;
reverse primer: 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTACCACAAGTGCGTC). To generate
Drp1K38A, the middle entry vector was mutated to change Lysine 38 to Alanine (forward primer: 5’CGCAGAGTAGCGGGGCGAGTTCAG; reverse primer: 5’-CCAAAACTGAACTCGCCCCGCTAC). All
expression plasmids were constructed by LR cloning using the 5kbneurod (Mo and Nicolson, 2011),
CMV/SP6, or Hsp701 5’ entry vectors and the pDestTol2pA2 destination vector. mRNA was
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synthesized using the SP6 mMessage Machine kit (Life Technologies). TALENs targeting exon 1 of
actr10 were designed using freeware (http://www.talendesign.org) and synthesized as described
(Dahlem et al., 2012); Tal1 target: AATTTCTGCTGATAAAATGC; Tal2 target: GGGCAGCGGAGGAGA).

Generation of the p150nl16 mutant and genotyping
The p150bnl16 mutant was generated using CRISPR/Cas9-mediated genome editing as described
(Hwang et al., 2013; Shah et al., 2015). Guide RNA targeting exon 3 (GGCGAGGGCAGCGC
TCCCAC) of the p150b locus was produced using a PCR-mediated scaffold method as described
(Gagnon et al., 2014). Cas9 mRNA (Chang et al., 2013) was produced using the SP6 mMessage
machine kit. Zygotes derived from p150a (moks309) heterozygous outcrosses were injected with 10
pg guide RNA and 100 pg Cas9 mRNA at the one cell stage. Progeny were raised until adulthood
and outcrossed to wildtypes to generate larvae. Larvae were genotyped using PCR amplification of
the exon 3 locus (forward primer: 5’-CGTGAGTGAGCTCTTGGTCTG; reverse primer: 5’-GCGTCTA
TAACCATGTTTGACCTTG) and cut with MwoI to identify insertions/deletions. Changes to the guide
RNA target result in loss of the MwoI cut site in p150b mutants: wildtype (164 bp + 64 bp) from
p150b mutants (224 bp).

In situ hybridization and antibody labeling
In situ hybridization and antibody labeling were done according to established protocols
(Drerup and Nechiporuk, 2013). The actr10 open reading frame was used for in situ hybridization.
An ~800 base pair portion the 3’UTR of p150a and p150b were used for in situ hybridization of these
paralogues. Antibodies used were: a-Dynein heavy chain (Protein Tech; #12345–1-AP); a-p150 (BD
Transduction Laboratories; #610473); a-Lamp1 (Iowa Hybridoma Bank, #1D4B); a-pJNK (Cell Signaling Technology, #9251S); a-GFP (Aves Labs Inc., #GFP-1020); a-DsRed (Clontech, #632496); a-Cytochrome c (BD Biosciences, #556432); a-GFP (Fisher Scientific, #A-11122); a-c-myc (Santa Cruz, #sc40); and a-ATPb (Abcam; #ab128743).

Cell culture, immunoprecipitation and mitochondrial fractionation
HEK293T cells (Sigma Aldrich; #12022001; identity authenticated by STR-PCR) were cultured according to standard protocols in DMEM with 50 U/mL Pen-Strep. Cells tested mycoplasma free (MycoAlert Mycoplasma Detection Kit; Lonza; L07-218). This human cell line was used for its transfection
ease and results were confirmed in vivo. Transfection was done in a 6-well plate using 2.5 mg total
DNA and 5 mL of Lipofectamine2000 per well according to manufacturer’s protocols (Thermo Fisher;
#11668027). The mammalian GFP-Actr10 clone was used previously (Yeh et al., 2012) and obtained
from Addgene (plasmid #51398). Drp1-myc and Drp1K38A-myc expression constructs were previously
described (Smirnova et al., 2001). GFP-Actr10 deletion constructs were made using the QuikChange II XL Site-Directed Mutagenesis kit (Agilent, #200521).
Mitochondrial fractionation was performed according to established protocols (Prudent et al.,
2013). Briefly, for each biological replicate 100 wildtype/heterozygous or actr10nl15 mutant larvae
were disrupted in 700 mL MB buffer (210 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM HEPES
pH = 7.5 and protease inhibitors) using a 26 gauge needle. After removal of the input fraction,
lysates were subjected to increasing centrifugation speeds to fractionate mitochondria from a heavy
and light fractions. The mitochondrial fraction was washed once in fresh MB buffer prior to addition
of Laemmli buffer to the pellet and heat denaturation. Extracts were run on a 10% acrylamide gel,
transferred to PVDF membrane, and incubated with antibodies prior to developing with the West
Pico Substrate (Thermo Fisher; #34080). After initial development, membranes were washed in water
and PBS/0.1% Tween prior to incubation with the a-ATPb antibody.

In vivo analysis of axonal transport
Axonal transport analyses were done as described (Drerup and Nechiporuk, 2013). Briefly, zygotes
were injected with plasmids to express cargos of interest tagged with fluorescent proteins. At 4 dpf,
larvae (each a biological replicate) were screened for pLL ganglion expression of cargo fusions and
imaged using a 63X/NA1.2 water objective on an FV1000 confocal microscope (Olympus). All imaging was done in a single z-plane, allowing acquisition at 2–4 frames per second, as required by the
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Nyquist sampling theorem (Nyquist, 1928). Kymograph analyses of cargo movement were performed using Metamorph (Molecular Devices).

Transmission electron microscopy
Zebrafish larvae at 5 dpf were fixed and prepared for TEM analysis using standard protocols
(Czopka and Lyons, 2011). Samples were embedded and sectioned from the tail of the larvae. An
ultramicrotome was used to cut 1000 nm sections, which were then stained with Toluidine Blue to
ensure the presence of neuromasts. Subsequently, 70 nm sections were cut and placed on copper
mesh grids. Grids were stained with uranyl acetate for one hour and then each grid was cleaned
with milliQ water for 45 s. The next day, grids were stained with Sato’s lead stain for 15 min and
again cleaned with milliQ water. The Washington University Center for Cellular Imaging Jeol JEM1400 (Jeol USA) electron microscope was used to observe samples and an AMT V601 camera captured images.

Image and statistical analyses
Volumetric analyses to determine mean fluorescence intensity of immunolabeling was done using
Imaris (Bitplane). For this analysis, a surface rendering was done using expression of the neurod:egfp
transgene in axon terminals and the mean fluorescence intensity was determined. Background from
the same channel was subtracted prior to analysis. For quantification of western blots, mean intensity
of was determined for signal and background using ImageJ. Statistical analyses were done in JMP.
Prior to parametric analyses, data normality and variance were determined. Parametric data was analyzed using ANOVAs with Tukey-Kramer HSD contrasts for multiple comparisons. Non-parametric
data was analyzed using Wilcoxon/Kruskal Wallis Tests. Image analyses and figure preparation was
done using ImageJ, Adobe Photoshop, and Adobe Illustrator.
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